Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Erythropoiesis”

152 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 152 results

Not applicableStudy completedNCT06851065
What this trial is testing

Evaluate Luspatercept Treatment Patterns and Outcomes in Erythropoiesis-Stimulating Agents-Naïve Patients With Lower-Risk Myelodysplastic Syndromes in the United States

Who this might be right for
Myelodysplastic Syndromes
Bristol-Myers Squibb 418
Not applicableStudy completedNCT04246021
What this trial is testing

Use of Intravenous Ferric Carboxymaltose in Treatment of Anemia in Cancer Patients Undergoing Chemotherapy

Who this might be right for
AnemiaCancer
King Hussein Cancer Center 84
Not applicableStudy completedNCT02136563
What this trial is testing

Renal Prognosis in Chronic Kidney Disease Patients With Hyporesponsive Anemia to Erythropoiesis Stimulating Agents

Who this might be right for
Renal AnemiaChronic Kidney Disease
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 2,000
Testing effectiveness (Phase 2)Study completedNCT00228449
What this trial is testing

Peginesatide for Anemia in Chronic Hemodialysis Patients

Who this might be right for
AnemiaChronic Kidney DiseaseChronic Renal Failure
Affymax 165
Large-scale testing (Phase 3)Study completedNCT00527137
What this trial is testing

NESP Pediatric Study

Who this might be right for
Pre-dialysisEnd Stage Renal Disease
Amgen 120
Large-scale testing (Phase 3)UnknownNCT05211167
What this trial is testing

Phase III Clinical Study of Recombinant Erythropoiesis Stimulating Protein Injection (rESP) in the Treatment of Anemia in Hemodialysis Patients With Chronic Renal Failure

Who this might be right for
Kidney Failure, ChronicHemodialysis
Shenyang Sunshine Pharmaceutical Co., LTD. 300
Not applicableStudy completedNCT01666301
What this trial is testing

ESAs, Reticulocyte Dynamic and Hemoglobin Variability

Who this might be right for
Erythropoiesis Stimulating Agent Pharmacodynamics
Ospedale Regionale di Locarno 31
Large-scale testing (Phase 3)Study completedNCT03409107
What this trial is testing

Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)

Who this might be right for
Anaemia
GlaxoSmithKline 614
Large-scale testing (Phase 3)Study completedNCT01381809
What this trial is testing

An Efficacy Study for Epoetin Alfa in Anemic Patients With Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes
Janssen-Cilag International NV 130
Testing effectiveness (Phase 2)Study completedNCT01977482
What this trial is testing

Evaluation of Dose Response Relationship, Safety and Efficacy of GSK1278863 in Hemodialysis-dependent Subjects With Chronic Kidney Disease Associated Anemia

Who this might be right for
Anaemia
GlaxoSmithKline 216
Testing effectiveness (Phase 2)Study completedNCT00001958
What this trial is testing

Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia)

Who this might be right for
Beta ThalassemiaHemoglobinopathy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 100
Large-scale testing (Phase 3)Study completedNCT03351166
What this trial is testing

Molidustat for Correction of Renal Anemia in Dialysis Subjects

Who this might be right for
AnemiaRenal Insufficiency, Chronic
Bayer 25
Large-scale testing (Phase 3)Study completedNCT04484857
What this trial is testing

Study of Roxadustat Conversion in Participants Receiving Stable ESA or as Initial Anemia Treatment in Hemodialysis Participants

Who this might be right for
Anemia Associated With End Stage Renal Disease
Kyntra Bio 283
Not applicableUnknownNCT06053866
What this trial is testing

Prevalence of Erythropoiesis Stimulating Agents Hyporesponsiveness in Dialysis Patients in Assiut University Hospital

Who this might be right for
Erythropoietin Resistant Anemia (EPO Resistant Anemia)
Assiut University 240
Testing effectiveness (Phase 2)Study completedNCT01587924
What this trial is testing

4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease

Who this might be right for
Anaemia
GlaxoSmithKline 80
Testing effectiveness (Phase 2)Study completedNCT01235923
What this trial is testing

Randomized Study of Weekly Erythropoietin Dosing in Preterm Infants

Who this might be right for
Preterm Infants
University of New Mexico 20
Testing effectiveness (Phase 2)Ended earlyNCT03140722
What this trial is testing

Study to Evaluate Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Who Are Hyporesponsive to Erythropoiesis Stimulating Agents

Who this might be right for
AnemiaDialysis-Dependent Chronic Kidney Disease
Akebia Therapeutics 2
Large-scale testing (Phase 3)Looking for participantsNCT07119372
What this trial is testing

Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis

Who this might be right for
AnemiaChronic Kidney DiseaseChronic Kidney Disease Patients on Hemodialysis+1 more
Biocad 228
Testing effectiveness (Phase 2)Looking for participantsNCT05384691
What this trial is testing

Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions

Who this might be right for
Myelodysplastic SyndromesAnemia
University of Leipzig 213
Large-scale testing (Phase 3)Active Not RecruitingNCT06901505
What this trial is testing

To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis

Who this might be right for
Anemia of Chronic Kidney Disease
Akebia Therapeutics 353
Load More Results